Literature DB >> 16047133

[Therapy for unilateral vocal fold palsy].

M Schuster1, U Eysholdt.   

Abstract

The main symptom of unilateral vocal fold palsy is hoarseness, which can cause considerable disturbance to the patient depending on its extent and the patient's individual situation. Therapy aims at the restitution of a tuneful and resilient voice, which can be achieved by surgical or conservative means, improving the glottal closure and synchronizing the vocal fold vibrations during phonation. Vocal therapy is a common conservative method that may be supported by psychotherapeutic or physical procedures. In surgical therapy, there is a distinction between techniques of endoscopic augmentation by injecting different materials into the vocal folds and transcutaneous laryngeal framework surgery, i.e., transferring the paralyzed vocal fold to the glottal midline. Particularly apt for injection are biocompatible materials amount and position whose can easily be controlled. However, the inevitable resorption of many materials causes deterioration in voice quality. Furthermore, the change of vocal fold morphology obstructs regular phonatory vibration. On the other hand, medialization thyroplasty leads to permanent voice amelioration without a substantial complication rate when performed by experienced surgeons.

Entities:  

Mesh:

Year:  2005        PMID: 16047133     DOI: 10.1007/s00106-005-1297-z

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  62 in total

1.  Direct autogenous fat implantation for augmentation of the vocal folds.

Authors:  H M Tucker
Journal:  J Voice       Date:  2001-12       Impact factor: 2.009

2.  Vocal rehabilitation of paralytic dysphonia. I. Cartilage injection into a paralyzed vocal cord.

Authors:  G E ARNOLD
Journal:  AMA Arch Otolaryngol       Date:  1955-07

Review 3.  Injection laryngoplasty.

Authors:  Mark S Courey
Journal:  Otolaryngol Clin North Am       Date:  2004-02       Impact factor: 3.346

4.  Validation of an instrument to measure voice-related quality of life (V-RQOL).

Authors:  N D Hogikyan; G Sethuraman
Journal:  J Voice       Date:  1999-12       Impact factor: 2.009

5.  Textured polydimethylsiloxane elastomers in the human larynx: safety and efficiency of use.

Authors:  C Sittel; W F Thumfart; C Pototschnig; C Wittekindt; H E Eckel
Journal:  J Biomed Mater Res       Date:  2000

6.  [Determination of subjective impairment in dysphonia. A methodological comparison].

Authors:  S Günther; T Rasch; M Klotz; U Hoppe; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

7.  [Initial experiences with collagen as a soft tissue implant in glottis insufficiencies].

Authors:  K Joussen
Journal:  HNO       Date:  1987-07       Impact factor: 1.284

8.  Viscoelastic properties of three vocal-fold injectable biomaterials at low audio frequencies.

Authors:  Sarah A Klemuk; Ingo R Titze
Journal:  Laryngoscope       Date:  2004-09       Impact factor: 3.325

9.  Lipoinjection for unilateral vocal cord paralysis.

Authors:  D O Mikaelian; L D Lowry; R T Sataloff
Journal:  Laryngoscope       Date:  1991-05       Impact factor: 3.325

10.  [Voice handicap in patients with organic and functional dysphonia].

Authors:  S Weigelt; S Krischke; M Klotz; U Hoppe; V Köllner; U Eysholdt; F Rosanowski
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

View more
  3 in total

1.  [Reinnervation and neurostimulation of the larynx].

Authors:  A H Müller; G Förster
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

2.  [Treatment of glottal gap].

Authors:  S Voigt-Zimmermann; C Arens
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

Review 3.  Diagnostic and therapeutic pitfalls in benign vocal fold diseases.

Authors:  Jörg Bohlender
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.